A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants

Clinical trial NCT05970718 · COMPLETED

Trial details

NCT number: NCT05970718
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-08-07
Primary completion: 2024-07-22
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.